Cannabidiol Market Size, Share, Trends, & Industry Analysis Report
By Product (CBD Oil, CBD Isolates), By Application, By Source, By Region – Market Forecast, 2025–2034
- Published Date:Sep-2025
- Pages: 112
- Format: PDF
- Report ID: PM2558
- Base Year: 2024
- Historical Data: 2020-2023
The global cannabidiol market is valued at USD 9.81 billion in 2024 and is projected to grow at a CAGR of 16.1% during the forecast period. Owing to it allay nature, the high request for CBD for healing and fitness motives is the prominent aspect driving the industry growth for cannabidiol. Moreover, the increasing adoption and utilization of CBD products by virtue of government authorization is another prime factor anticipated to propel the production of CBD-derived products in the cannabidiol market.
Key Insights
- The hemp segment is expected to witness significant growth due to growing demand from healthcare industry.
- The pharmaceutical segment accounted for the largest share in 2024 driven by continuous R&D activity.
- North America dominated with largest share in 2024 due to rising adoption of CBD-derived products.
- Europe is projected to accounted for a significant share in the global market due to presence of major pharmaceutical industry.
Industry Dynamics
- The rising adoption of CBD in wide range of consumer products is fueling the industry growth.
- The increasing awareness of usage of cannabis in beauty care product is boosting the industry growth.
- The legitimization of cannabis is driving the growth.
- Regulatory uncertainty and inconsistent legal frameworks across countries and regions are limiting product distribution and consumer trust.
Market Statistics
- 2024 Market Size: USD 9.81 Billion
- 2034 Projected Market Size: USD 43.66 Billion
- CAGR (2025-2034): 16.1%
- Largest Market: North America
To Understand More About this Research: Request a Free Sample Report
Cannabidiol has derived from Sativa flora and is drawn out from cannabis or hemp, basically from hemp because of its organically top CBD holder. Cannabidiol has various healthy advantages in the treatment of seizures, anxiety, and body pain relaxation.
The robust demand for remedies, medication, and other consumer & healing products prepared from cannabis and its effective well-being advantages has evolved into inflaming permissions for CBD-derived products for the public welfare. The U.S FDA (Food and Drug Administration) has validated various possible opportunities that cannabis will provide and recognized the probability of saturating it in several medical and food applications. Although, the FDA is functioning to safeguard communal health and enhance the coherence of the administrative path to produce mankind's suitable products. The cannabidiol market players are supervised on bearing out CBD to utilize the same in food, personal health care, pharmaceutical, and other remedy products are some aspects rising the growth of the global cannabidiol market during the projection period.
Clinical examinations administered on CBD have rendered its effectiveness in the diagnosis of many types of epilepsy. Emerging nations are looking to manufacture CBD-derived pharmaceuticals, which will remarkably give rise to huge demand, which in turn boost the market demand for cannabidiol.
Industry Dynamics
Growth Drivers
The rising adoption of CBD in various consumer products because of the developing buyers' inclination towards CBD-derived products and compliance with therapeutics cannabidiol-based products for cancer-suffering patients to reduce pain is driving the demand. This adoption is fuel by rising awareness regarding the utilization of cannabis. Moreover, the increasing use of cannabis in beauty care products, stress relief, medical applications, food & beverages, road accident injured patients, and supplements is further fueling the growth. Furthermore, the ongoing research & development activities and huge funding by the pharmaceutical industry players to capture the largest revenue share is fueling the growth.
Additionally, the legitimization of cannabis has decreased the requirement for regular authorization from different government departments. Key industry players are preparing their eCommerce platforms (website & apps) for the legal and transparent sales of cannabidiol-prepared products, which are some factors driving the growth of the market during the forecast period.
Report Segmentation
The market is primarily segmented based on by product, application, source, and regions.
|
By Product |
By Application |
By Source |
By Region |
|
|
|
|
Know more about this report: Request for sample pages
Marijuana segment dominated with largest share in 2024
The marijuana section dominated the market in 2021. The rising adoption of improved CBD-based products and the surge in the legalization of marijuana-obtained products for major health diagnosis applications are driving the growth of the segment. Moreover, the top-notch efficacy of cannabidiol procured from marijuana is a major aspect propelling the segment's growth in the gross market.
Hemp-obtained cannabidiol is expected to register lucrative growth due to the booming request from the healthcare industry and growing perception amidst end users' reference to health & fitness, plus consumer per capita income along with the government favorable policies for pharmaceutical cannabis is expected to showcase cogent impact on the huge demand for cannabidiol in the therapeutics category.
Utilization of tinctures, oils, concentrate, topical solutions, and capsules in end-user products, likely slaves, body lotions, lip balms, and succulents such as coffee, gums, chocolates, baked goods, and candies are some of the CBD-prepared products that are in huge demand from the consumer side.
Pharmaceutical sector dominated the market share in 2024
The pharmaceutical sector is one of the prominent industries that continue aiming for advancements, new product launches, and R&D activities in the market. The key players have found a massive gravity of CBD in their product production due to its large contribution, namely immunomodulatory attributes, pain reduction, and others. The rising digit of drug trials to examine the physical effects of CBD on individual health situations is expected to boost the product needs in recent years. Although, key players combined CBD oils in the mass production of CBD-derived products. These products are consumed by a huge educated and aware consumer as an anxiety and mental stress relief substitute.
North America region leads the global cannabidiol market in 2024
In North America, the existence of a great number of fitness-oriented citizens in the province, enlarging adoption of CBD-derived products, the occupancy of key industrialists, and legal authorization from the U.S. government are some of the prime aspects of developing the topographical market. North America is considered to be the ultra-competitive region for cannabis and associated outcomes, counting cannabidiol. The USA alone has the largest CBD manufacturers and sympathetic regulations towards the usage of CBD-obtained products.
The Europe is expected to witness significant growth during the forecast period due to rise in demand for the natural wellness product. Cannabidiol is used in natural wellness products because of its non-psychoactive, plant-based properties and its potential health benefits without the “high” associated with THC. Moreover, growing acceptance of CBD and change in perception is further fueling the demand in various therapeutic application. The governments in the European countries such as Germany and UK have passed regulation related to potential use of cannabis related product which further drives the growth in the region.
Competitive Insight
Some of the key players operating in the global cannabidiol (CBD) market include ENDOCA, Medical Marijuana Inc., Aurora Cannabis, Folium Biosciences, Elixinol Global, Canopy Growth Corporation, NuLeaf Naturals, IRIE CBD, Medterra CBD, LLC, CBD American Shaman, Cannoid, Isodiol International Inc., Aurora Cannabis Inc., Gaia Herbs, LLC, CV Sciences, Pharmahemp d.o.o, and others.
Recent Developments
In January 2022, CV Sciences, Inc. notify the introduction of +PlusCBD pain relief topicals with four isolated OTC products prepared to the precision root of trivial aches and pain. This product inauguration is anticipated to authorize the firm to enlarge its +PlusCBD product provisioning.
In June 2021, The Valens Company settled the possession of Green Roads for about US $ 60 million. The acquisition includes The Valens organization obtain into the U.S. CBD product market through a full-grown system of Green Roads.
In June 2021, Vertical Wellness, the US-originated firm, collaborated with CanaFarma Hemp Products Corp. a Canada-situated organization, which produces many hemp-derived products and supplements. This union will serve Vertical Wellness remodel into a public organization with gross assets of US $50 million.
Cannabidiol Market Report Scope
|
Report Attributes |
Details |
|
Market size value in 2024 |
USD 9.81 billion |
| Market size value in 2025 | USD 11.36 billion |
|
Revenue forecast in 2034 |
USD 43.66 billion |
|
CAGR |
16.1% from 2025 – 2034 |
|
Base year |
2024 |
|
Historical data |
2020 – 2023 |
|
Forecast period |
2025 – 2034 |
|
Quantitative units |
Revenue in USD billion and CAGR from 2025 to 2034 |
|
Segments covered |
Product Type, Application, Source, and Region |
|
Regional scope |
North America, Europe, Asia Pacific, Latin America; Middle East & Africa |
|
Key companies |
ENDOCA, Medical Marijuana Inc., Aurora Cannabis, Folium Biosciences, Elixinol Global, Canopy Growth Corporation, NuLeaf Naturals, IRIE CBD, Medterra CBD, LLC, CBD American Shaman, Cannoid, Isodiol International Inc., Aurora Cannabis Inc., Gaia Herbs, LLC, CV Sciences, Pharmahemp d.o.o, and others. |
FAQ's
• The market size was valued at USD 9.81 Billion in 2024 and is projected to grow to USD 43.66 Billion by 2034.
• The market is projected to register a CAGR of 16.1% during the forecast period.
• A few of the key players in the market are ENDOCA, Medical Marijuana Inc., Aurora Cannabis, Folium Biosciences, Elixinol Global, Canopy Growth Corporation, NuLeaf Naturals, IRIE CBD, Medterra CBD, LLC, CBD American Shaman, Cannoid, Isodiol International Inc., Aurora Cannabis Inc., Gaia Herbs, LLC, CV Sciences, Pharmahemp d.o.o, and others.
• The pharmaceutical accounted for the largest market share in 2024.
• The hemp segment is expected to record significant growth.
© 2025 Polaris Market Research and Consulting. All rights reserved
